منابع مشابه
Exercise and Intermittent Claudication
Four men with arteriosclerosis obliterans (ASO) were exercised on a treadmill on 4 different days to determine their maximal walking time (MWT) and the point at which their claudication pain (CPT) began. Each subject was exercised at 60%, 75%, and 90% of his MWT to determine the effect of work intensity on the systolic blood pressure at the ankle (AP). To measure the effect of exercise repeated...
متن کاملExercise and Intermittent Claudication
Nineteen patients with obliterative arteriosclerotic disease of the legs and suffering from intermittent claudication were studied before and during a 6 months' training program. The maximal walking distance and the calf muscle blood flow during walking (xenon-133 clearance technique) was recorded at monthly intervals. A significant correlation was established between improvement in maximal wal...
متن کاملAn exercise test in intermittent claudication.
In most cases of intermittent claudication the diagnosis is apparent after the history and clinical examination have been completed. Although the history itself may be misleading, clinical examination is usually fruitful; the signs of obliterative arterial disease are present in most, and cases of anrmia and coarctation of the aorta that present with intermittent claudication should be easily d...
متن کاملPentoxifylline for intermittent claudication.
BACKGROUND Intermittent claudication (IC) is a symptom of peripheral arterial disease (PAD) and is associated with high morbidity and mortality. Pentoxifylline, one of many drugs used to treat IC, acts by decreasing blood viscosity, improving erythrocyte flexibility and promoting microcirculatory flow and tissue oxygen concentration. Many studies have evaluated the efficacy of pentoxifylline in...
متن کاملBuflomedil for intermittent claudication.
BACKGROUND Intermittent claudication (IC) is pain caused by chronic occlusive arterial disease, that develops in a limb during exercise and is relieved with rest. Buflomedil is a vasoactive agent used to treat peripheral vascular disease. However, its clinical efficacy for IC has not yet been critically examined. This is an update of a Cochrane review first published in 2000, and previously upd...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Physical Therapy
سال: 2011
ISSN: 0031-9023,1538-6724
DOI: 10.2522/ptj.20100419